๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-06

FSL2 Post Approval Study for Pediatric and Young Adults Patients (NCT04959552)

FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study- FreeStyle Libre 2

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Abbott Diabetes Care

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of the FreeStyle Libre 2 Flash Glucose Monitoring System when used to manage diabetes in pediatric and young adult patient populations.

Who can join: Review the eligibility criteria below.

Location: Yale Pediatric Endocrinology Clinic โ€” New Haven, Connecticut

Age range: 4 Years to 30 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (3 Sites)

  • Yale Pediatric Endocrinology Clinic โ€” New Haven, Connecticut
  • The Children's Mercy Hospital โ€” Kansas City, Missouri
  • The DOCS โ€” Las Vegas, Nevada

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Diabete Mellitus clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—